Delivery of genetic information to the interior of target cells in vivo has been a major
challenge facing gene therapies. This barrier is now being overcome, owing in part to …

The development of the Coronavirus disease 2019 (COVID-19) vaccine is one of the most
important efforts in controlling the pandemic. Serological tests are used to identify highly …

We quantitatively analyzed SARS-CoV-2 antibody levels in patients after two doses of the
ChAdOx1 nCoV-19 vaccine and the third BNT162b2 booster. We obtained 255 serum …

Background Mucosal antibodies play a critical role in preventing SARS-CoV-2 infections or
reinfections by blocking the interaction of the receptor-binding domain (RBD) with the …

Differences in vaccination coverage can perpetuate coronavirus disease 2019 (COVID-19)
disparities. We explored the association between neighborhood-level social vulnerability …

Introduction The differential immune responses after two additional BNT162b2 (BNT)
booster doses between ChAdOx1 nCoV-10 (ChAd)-primed and BNT-primed groups have …

Background Waning protection against emerging SARS-CoV-2 variants by pre-existing
antibodies elicited because of current vaccination or natural infection is a global concern …

Objective Class III obesity (body mass index [BMI]≥ 40 kg m− 2) significantly impairs the
immune response to SARS‐CoV‐2 vaccination. However, the effect of an elevated BMI (≥ …

Background Although it is well known that the older people have been the most susceptible
to COVID-19, there are conflicting data on the susceptibility of centenarians. Two …

January 2022 is the second anniversary of the identification of Coronavirus disease 2019
(COVID-19) 1 caused by severe acute respiratory syndrome (SARS) coronavirus 2 (SARS …